Suprefact 1mg/ml 5,5ml 2st
Suprefact 1mg/ml 5,5ml 2st
Buserelin acts by blockade and subsequent down-regulation of pituitary LHRH receptor synthesis. Gonadotropin release is consequently inhibited. As a result of this inhibition there is reduced stimulation of testosterone secretion and serum testosterone levels fall to castration range. Before inhibition occurs there is a brief stimulatory phase during which testosterone levels may rise.
Buserelin is a synthetic peptide. It is a superactive analogue of natural gonadotrophin releasing hormone (gonadorelin, LHRH or GNRH). After an initial stimulation of gonodotrophin release, it down-regulates the hypothalamic-pituitary-gonadal axis.
Indicaciones de uso
Unopened: 2 years.
Once opened use within 15 days.
Do not store above 25°C. Do not freeze. Keep the vials in the outer carton in order to protect from light.
Box of 1 x 5.5 ml multidose vials each containing 1.05 mg burserelin acetate per 1 ml, corresponding to 1.00 mg burserelin per 1 ml.
Pack size: 2 individual cardboard boxes are wrapped together in a clear plastic outer.
Suprefact Injection contains 1.00mg buserelin as buserelin acetate in 1ml aqueous solution. 1.00mg buserelin is equivalent to 1.05mg buserelin acetate.
- Sodium Chloride
- Sodium Dihydrogen Phosphate
- Sodium Hydroxide
- Benzyl Alcohol (10mg/ml)
- Water for injections